✦ LIBER ✦

Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis

✍ Scribed by Khairuddin Memon; Laura Kulik; Robert J. Lewandowski; Edward Wang; Robert K. Ryu; Ahsun Riaz; Paul Nikolaidis; Frank H. Miller; Vahid Yaghmai; Talia Baker; Michael Abecassis; Al B. Benson 3rd; Mary F. Mulcahy; Reed A. Omary; Riad Salem

Book ID: 116652671
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 982 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2011.11.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abstract No. 243: Alpha-fetoprotein resp

Abstract No. 243: Alpha-fetoprotein response correlates with EASL response and survival in hepatocellular carcinoma patients treated with locoregional therapies

✍ Memon, K.; Kulik, L.M.; Lewandowski, R.J.; Sato, K.T.; Riaz, A.; Ryu, R.K.; Omar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Do EASL and mRECIST responses have indep

Do EASL and mRECIST responses have independent effects on survival in hepatocellular carcinoma patients treated with transarterial embolization?

✍ Weijuan Wang; Yan Zhao; Guohong Han; Daiming Fan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 386 KB

Reply to: “Do EASL and mRECIST responses

Reply to: “Do EASL and mRECIST responses have independent effects on survival in hepatocellular carcinoma patients treated with transarterial embolization?”

✍ Tim Meyer; Amy Kirkwood; Roopinder Gillmore 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Abstract No. 219: Correlation of surviva

Abstract No. 219: Correlation of survival and tumor response with WHO, RECIST, EASL and mRECIST criteria after doxorubicin drug eluting beads transarterial chemoembolization (DEB TACE) in unresectable hepatocellular carcinoma (HCC)

✍ Prajapati, H.J.; Chen, Z.; Spivey, J.R.; Hanish, S.I.; El-Rayes, B.; Kauh, J.; K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 46 KB